Viewing Gene With Clinical Trials Data


Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/

Symbol: HGD
Name: homogentisate 12-dioxygenase
Location: 03q13.33
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product

Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT00628784 Endoesophageal Cryotherapy For Ablating Barretts Esophagus and Early Stage Esophageal Cancer View
NCT04224896 Narrow-Band Imaging NBI Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population View
NCT04869618 Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer View
NCT04906343 Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia View
NCT05524844 The Microbiome Bile Acids and Notch in Barretts Esophagus BE View
NCT03278327 Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barretts Oesophagus View
NCT01203163 Case Analysis on Real Life Incidence of Photodynamic Therapy PDT Safety Outcomes View
NCT00526786 Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barretts Esophagus View
NCT00576498 Novel Imaging Techniques in Barretts Esophagus View
NCT02694120 Study on Complications EfficAcy and Costs of Large Polypectomy View
NCT01618643 Aceto-whitening in the Assessment of Gastrointestinal Neoplasia View
NCT00848237 HALO Patient Registry Ablation of Barretts Esophagus View
NCT02200250 Long Term Barretts Endoscopic Mucosal Resection Study View
NCT02396745 TECR ECM Placement for Esophageal High Grade Dysplasia View
NCT01572974 Quality of Life in Barretts Esophagus and Gastro-Esophageal Reflux Disease View
NCT01882478 Cryotherapy -BEATS-RF Ablation Trial View
NCT02162758 Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barretts Esophagus With Radiofrequency Ablation View
NCT03526328 DCLK1 as a MarkerIndicator of Stem Cell Response in Barretts EsophagusEsophageal Adenocarcinoma View
NCT05642338 A Multicenter Prospective Cohort Study Comparing Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling WATS for Surveillance of Barretts Esophagus the WATS-EURO2 Study View
NCT03820531 DNA-mutation Analysis in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas View
NCT04457193 Outcomes After Transoral Incisionless Fundoplication TIF Following Successful Endoscopic Ablation for Barretts Esophagus View
NCT03205501 Molecular Fluorescence Endoscopy of PreMalignant Esophageal Lesions View
NCT00586404 The Study of Barretts Esophagus What Are the Factors of Progression View
NCT00650988 Cryotherapy for Barretts Esophagus and Early Esophageal Cancers View
NCT02129933 VEGF-targeted Fluorescence Near-Infrared NIR Endoscopy in PreMalignant Esophageal Lesions View
NCT01209013 Safety of Photodynamic Therapy PDT in the Ablation of High-grade Dysplasia HGD in Barretts Esophagus BE View